GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmadrug Inc (XCNQ:PHRX) » Definitions » Cyclically Adjusted Price-to-FCF

Pharmadrug (XCNQ:PHRX) Cyclically Adjusted Price-to-FCF : (As of Jun. 06, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Pharmadrug Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Pharmadrug Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Pharmadrug's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmadrug Cyclically Adjusted Price-to-FCF Chart

Pharmadrug Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pharmadrug Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pharmadrug's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmadrug's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmadrug's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmadrug's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Pharmadrug's Cyclically Adjusted Price-to-FCF falls into.



Pharmadrug Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Pharmadrug's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Pharmadrug's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0/125.0724*125.0724
=0.000

Current CPI (Dec. 2023) = 125.0724.

Pharmadrug Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -0.741 98.604 -0.940
201406 -0.623 99.473 -0.783
201409 -1.055 99.394 -1.328
201412 -1.941 98.367 -2.468
201503 -0.387 99.789 -0.485
201506 -0.126 100.500 -0.157
201509 -0.129 100.421 -0.161
201512 -0.248 99.947 -0.310
201603 -0.051 101.054 -0.063
201606 -0.032 102.002 -0.039
201609 -0.025 101.765 -0.031
201612 -0.012 101.449 -0.015
201703 -0.082 102.634 -0.100
201706 -0.129 103.029 -0.157
201709 -0.037 103.345 -0.045
201712 0.005 103.345 0.006
201803 0.000 105.004 0.000
201806 -0.069 105.557 -0.082
201809 -0.286 105.636 -0.339
201812 -0.043 105.399 -0.051
201903 -0.039 106.979 -0.046
201906 -0.181 107.690 -0.210
201909 -0.027 107.611 -0.031
201912 0.023 107.769 0.027
202003 -0.013 107.927 -0.015
202006 -0.033 108.401 -0.038
202009 -0.018 108.164 -0.021
202012 -0.025 108.559 -0.029
202103 -0.033 110.298 -0.037
202106 -0.015 111.720 -0.017
202109 -0.018 112.905 -0.020
202112 -0.023 113.774 -0.025
202203 -0.026 117.646 -0.028
202206 -0.012 120.806 -0.012
202209 -0.065 120.648 -0.067
202212 0.056 120.964 0.058
202303 -0.002 122.702 -0.002
202306 -0.003 124.203 -0.003
202309 -0.004 125.230 -0.004
202312 0.000 125.072 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pharmadrug  (XCNQ:PHRX) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Pharmadrug Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Pharmadrug's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmadrug (XCNQ:PHRX) Business Description

Industry
Traded in Other Exchanges
Address
77 King Street West, Suite 2905, Toronto, ON, CAN, M5K 1H1
Pharmadrug Inc is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and naturally derived approved drugs. The Company's operations comprise of the corporate division in Canada. Geographically, it operates in Germany and Canada.

Pharmadrug (XCNQ:PHRX) Headlines

No Headlines